Overview

Sublingual Misoprostol and Tranexamic Acid in Pregnant Women With Twin Pregnancy Undergoing Cesarean Section

Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
0
Participant gender:
Female
Summary
Purpose to evaluate the effects of sublingual misoprostol with or without intravenous tranexamic acid (TA) in comparison with placebo on reducing post-partum hemorrhage in pregnant women with twin pregnancy undergoing an elective cesarean section.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Aswan University Hospital
Treatments:
Misoprostol
Tranexamic Acid
Criteria
Inclusion Criteria:

- women with a multiple term pregnancy undergoing elective cesarean section

Exclusion Criteria:

- single gestation

- placenta praevia and placental abruption

- undergoing cesarean section with general anesthesia

- women undergoing cesarean section at less than 37 weeks of gestation

- with a severe medical disorder

- allergy to tranexamic acid or misoprostol